Evidence map›Paper›PMID 28792004›Full record

ArticleMucosal immunology2018

Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4

D R Frederick, J A Goggins, L M Sabbagh, L C Freytag, J D Clements, J B McLachlan

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Effects ofFrontiers in immunology · 2025
    Article
  9. Review
  10. Review
  11. Effects ofFrontiers in pharmacology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Mucosal vaccines - fortifying the frontiers.Nature reviews. Immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

D R FrederickDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
J A GogginsDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
L M SabbaghDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
L C FreytagDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
J D ClementsDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
J B McLachlanDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Tulane University · US

Funding

Using combination adjuvants to direct and control immune responses at the intestinal mucosaU01AI124289 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MCLACHLAN, JAMES B · 2016 to 2020
$2.4M
Organ-specific CD4 T cell responses regulate Salmonella persistenceR01AI103343 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MCLACHLAN, JAMES B · 2013 to 2016
$1.5M
NIAID NIH HHS R01 AI103343NIAID NIH HHS U01 AI124289
6 · The paper itself

Abstract

Infectious diarrheal diseases are the second leading cause of death in children under 5 years, making vaccines against these diseases a high priority. It is known that certain vaccine adjuvants, chiefly bacterial ADP-ribosylating enterotoxins, can induce mucosal antibodies when delivered parenterally. Based on this, we reasoned vaccine-specific mucosal cellular immunity could be induced via parenteral immunization with these adjuvants. Here, we show that, in contrast to the Toll-like receptor-9 agonist CpG, intradermal immunization with non-toxic double-mutant heat-labile toxin (dmLT) from enterotoxigenic Escherichia coli drove endogenous, antigen-specific CD4

Indexed as

Adjuvants, ImmunologicAnimalsCD4-Positive T-LymphocytesCell MovementCells, CulturedDendritic CellsDiarrheaEnterotoxigenic Escherichia coliEnterotoxinsEscherichia coli InfectionsEscherichia coli ProteinsEscherichia coli VaccinesHumansImmunity, MucosalImmunizationInfusions, ParenteralAdjuvants, ImmunologicEnterotoxinsEscherichia coli ProteinsEscherichia coli VaccinesIntegrin alpha4integrin beta7Integrin beta ChainsReceptors, Lymphocyte Homing

Identifiers

PMID28792004
PMCPMC6252260
OpenAlexW2742771956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.